Likewise, lowering protein Kla levels—either by using the antagonist a-485 to inhibit p300 and block protein Kla formation or by knocking out LDHA—can greatly reduce neuronal death and astrocyte activation in cerebral ischemia, extend the reperfusion window, and improve functional recovery from ischemic stroke 204. Here, KL is linked to ischemic stroke.